"This is the best use of my time to remain current with what is going on in the industry."
Event date: 09/07/2025 Export event
Birds-of-a-Feather Round Table Discussion: “A Chat about eCOA”
Date: Wed, 9-July-2025 Duration: One hour
Facilitators: Leigh Bobowski: Pfizer, Director, Group Lead, CDS, Clinical Data and Information Sciences
Siva Bala: Pfizer, eCOA Lead (Patient Data Strategies), Clinical Data and Information Sciences
Time – UTC: 1400 (NYC: 10am, Brussels 4pm, Beijing: 10pm) We apologize for the inconvenient time in some time zones. Please feel free to forward this invitation to your colleagues within your organization.
Background: eClinical Forum Birds-of-a-Feather webinar sessions focus on the details of a specific topic. All participants are encouraged to share information and ask questions. Anyone from an eCF member company can participate, gratis. The facilitator will [try to] keep the subject on track and prompt discussion and information sharing.
For This Topic: This session is not intended to provide firm answers to the below questions. It is about exchanging views with other participants and gaining insights into the different challenges and needs. This is a round-table discussion. Participants are encouraged to share experiences, make comments, ask questions, and contribute to the discussion. To encourage candid discussion, we will not be recording this session.
Continuing the discussions started at the Spring workshops ... we will be discussing:
Insights on the standardization of instruments within your organization ...
Experiences with implementing eCOA builds in-house
Experiences with MFA : Any patient feedback on MFA vs simple login (PIN or PWD)
Experiences with implementation of 'Reason Not Performed' (QSREASND) in QS domains as outlined in Section 4.1.2.2 of the "Handling of Missing Data in Submitting Clinical Trial Datasets and Documentation for Clinical Outcome Assessments Using Item Response Theory" and Section 3.1.1.2 of the "Handling of Missing PRO Data Submitting Patient-Reported Outcome Data in Cancer Clinical Trials."
Any considerations and learnings you can share from your experience with this implementation ?
Open To: Staff from eClinical Forum member companies gratis (If your organisation is not an eCF member, please review our website Membership for membership information or contact info@eclinicalforum.org )
eCF Members can register here: eCF BoF Round-Table: "A Chat about eCOA"
eCF Views & News
We send out a brief monthly newsletter via email to all our active eCF members to keep them abreast of the activities of eCF that they can participate in. The more who participate, the better we are "A Network Powered by Peers". Click to see the most current newsletter.
(04/11/2025 - 06/11/2025)
(04/11/2025 13:00 - 06/11/2025 15:00)
Registration for the eCF Asia Autumn workshop is now open!
We are happy to announce the topics and registration for the eClinical Forum workshop to be hosted by Kyowa Kirin, in Tokyo Japan on November 13-14, 2025.
The workshop will be available for in-person participation only. There will be a networking/social event in the evening. Each eCF Member company can use 1 or 2 seats depending on your membership type and as allocated by your eCF Primary Representative. For those wishing to attend a remote eCF workshop, the eCF European workshop in London on Nov 4-6 will have similar topics and will be live-streamed. Click to get more information on the planned topics. Register here
Technology Showcase: eClinical Solutions: elluminate Assist – AI-driven SDTM study data analysis assistant
This is an eClinical Forum Technology Showcase. Our Technology Showcase sessions have been requested by eCF members to provide a demonstration of products or services, and by necessity are not technology or vendor neutral. The eClinical Forum does not promote nor endorse any particular technology vendors. Any member can participate that has an interest in the topic area. Any eClinical Forum Member may suggest or present a Technology Showcase. READ MORE for details on this Technology Showcase.